AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $67,000 | -42.7% | 1,300 | -51.9% | 0.04% | -41.9% |
| Q4 2020 | $117,000 | +178.6% | 2,700 | +125.0% | 0.07% | +124.2% |
| Q3 2020 | $42,000 | -64.4% | 1,200 | -45.5% | 0.03% | -67.3% |
| Q2 2020 | $118,000 | +51.3% | 2,200 | 0.0% | 0.10% | +31.2% |
| Q1 2020 | $78,000 | -25.7% | 2,200 | 0.0% | 0.08% | -10.5% |
| Q4 2019 | $105,000 | -47.0% | 2,200 | -63.9% | 0.09% | -57.0% |
| Q3 2019 | $198,000 | -22.0% | 6,100 | +19.6% | 0.20% | +65.3% |
| Q2 2019 | $254,000 | -39.2% | 5,100 | -17.7% | 0.12% | -25.8% |
| Q1 2019 | $418,000 | -19.8% | 6,200 | -45.1% | 0.16% | -32.6% |
| Q4 2018 | $521,000 | -28.7% | 11,300 | +18.9% | 0.24% | -15.4% |
| Q3 2018 | $731,000 | -8.5% | 9,500 | 0.0% | 0.29% | -6.2% |
| Q2 2018 | $799,000 | – | 9,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |